Su questa pagina
01DVA prezzo
02Snapshot
03Grafico
04Split azionari
05Chi siamo
06Performance
07Valutazione e rapporti
13Dividendi
14Utili
15Fondamentali Completi
16Bilanci
17Proprietari istituzionali (13F)
18Attivisti e proprietari del 5%+
19Insider aziendali
20Proprietà ETF
21Consenso
22Peer
25Segnali di trading
26Le Mie Metriche
DVA DaVita Inc. Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 4, 2026
$178,69
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$101,00minimo 52 sett.
$247,49massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Ricavi (TTM)
$14.01B
i tuoi badge
Intervallo 52 sett.
$101–$247
Rating Analisti
BUY
Prezzo Obiettivo
$220
P/E
14.7
ROE
-149.4%
Margine di Profitto Netto
6.0%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
DVA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$178.69
Capitalizzazione di Mercato (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Ricavi (TTM)
$14.01B
Rendimento div.
0.00%
ROE (TTM)
-149.4%
Intervallo 52 sett.
$101–$247
DVA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 09 Settembre 2013 | 2-for-1 | Avanti |
| 16 Giugno 2004 | 3-for-2 | Avanti |
| 21 Ottobre 1997 | 5-for-3 | Avanti |
Informazioni su DaVita Inc. Common Stock Panoramica della società da Wikipedia
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
settoreHealth Care
industriaHealth Care
dipendenti78.000
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
Flusso di cassa libero$1.31B2016-12-31 → 2025-12-31
Margine netto6.0%2018-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | DVA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 14.7media 5 anni ≈13.0 | ≈13.0 | 23.4 | Sottovalutato | |
| P/S (TTM) | 0.8media 5 anni ≈0.8 | ≈0.8 | 1.8 | Sottovalutato | |
| P/B (MRQ) | -14.9media 5 anni ≈24.1 | ≈24.1 | · | · | |
| Prezzo / FCF (TTM) | 7.1media 5 anni ≈7.2 | ≈7.2 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 5.2media 5 anni ≈4.9 | ≈4.9 | 11.3 | Sottovalutato | |
| Prezzo / Valore contabile tangibile (MRQ) | -11.5 | · | · | · | |
| PEG Ratio | ≈1.6 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | DVA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 15.2%media 5 anni ≈14.3% | ≈14.3% | 9.2% | Di prim'ordine | |
| Margine EBITDA (TTM) | 20.2%media 5 anni ≈20.1% | ≈20.1% | 12.7% | Di prim'ordine | |
| Margine ante imposte (TTM) | 10.5%media 5 anni ≈10.6% | ≈10.6% | 4.3% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 6.0%media 5 anni ≈6.3% | ≈6.3% | 5.1% | Di prim'ordine | |
| ROA (TTM) | 4.8%media 5 anni ≈4.6% | ≈4.6% | 3.7% | Di prim'ordine | |
| ROE (TTM) | -149.4%media 5 anni ≈24.7% | ≈24.7% | 10.5% | Debole | |
| ROIC | -245.6%media 5 anni ≈325.5% | ≈325.5% | 5.1% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | DVA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.5media 5 anni ≈1.3 | ≈1.3 | 1.5 | In linea | |
| Quick Ratio (MRQ) | 1.1media 5 anni ≈1.0 | ≈1.0 | 1.0 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | DVA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 6.5%media 5 anni ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 5.5%media 5 anni ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 3.4% | · | · | · | |
| EPS YoY | -8.3%media 5 anni ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (Utile Netto YoY) | -20.2%media 5 anni ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 18.9%media 5 anni ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | 10.0%media 5 anni ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | -0.70% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | DVA | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.8media 5 anni ≈0.7 | ≈0.7 | 0.8 | In linea | |
| Receivables Turnover (Rotazione dei crediti) | 6.0media 5 anni ≈6.0 | ≈6.0 | 10.6 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$174.9K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield0.00%
Rapporto di Distribuzione Utili0.00%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.05%
Prossimo report
Ott 27, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 3, 2026 | $4.02 | $3.92 | 2.5% |
| 31 Marzo 2026 | Mag 11, 2026 | $2.87 | $2.34 | 22.6% |
| 31 Dicembre 2025 | $3.40 | $3.19 | 6.7% | |
| 30 Settembre 2025 | $2.04 | $3.25 | -37.3% | |
| 30 Giugno 2025 | $2.95 | $2.83 | 4.2% | |
| 31 Marzo 2025 | $2.00 | $1.97 | 1.7% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Margine Operativo % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Utile netto | $747M | $936M | $692M | $560M | $978M |
| EPS Diluito | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Proprietari istituzionali (13F) 692 filer · $13.6B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
692
Valore detenuto
$13.6B
Nuove posizioni
126
Posizioni chiuse
61
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 126 (-14 vs trimestre precedente) | 61 (-2 vs trimestre precedente) | 195 (+23 vs trimestre precedente) | 226 (+12 vs trimestre precedente) | -1.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6.425.268.898 | 28.880.209 | 47,23% | Azioni |
| BlackRock, Inc. | $547.520.494 | 2.460.987 | 4,02% | Azioni |
| VANGUARD GROUP INC | $471.976.159 | 4.154.354 | 3,47% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $467.525.034 | 2.101.425 | 3,44% | Azioni |
| MORGAN STANLEY | $356.348.822 | 1.601.710 | 2,62% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306.558.307 | 1.377.914 | 2,25% | Azioni |
| STATE STREET CORP | $294.345.267 | 1.323.019 | 2,16% | Azioni |
| Invesco Ltd. | $269.627.293 | 1.211.917 | 1,98% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $253.130.449 | 1.137.814 | 1,86% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $205.758.498 | 925.579 | 1,51% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197.802.963 | 889.082 | 1,45% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $189.562.167 | 853.602 | 1,39% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163.166.832 | 733.400 | 1,20% | Opzione Call |
| Gates Capital Management, Inc. | $153.096.497 | 688.136 | 1,13% | Azioni |
| BANK OF AMERICA CORP /DE/ | $145.056.737 | 651.999 | 1,07% | Azioni |
| D. E. Shaw & Co., Inc. | $142.571.191 | 640.827 | 1,05% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $128.131.338 | 587.758 | 0,94% | Azioni |
| GOLDMAN SACHS GROUP INC | $103.093.004 | 463.381 | 0,76% | Azioni |
| Bank of New York Mellon Corp | $101.127.189 | 454.545 | 0,74% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $87.427.043 | 395.687 | 0,64% | Azioni |
| NORTHERN TRUST CORP | $84.995.593 | 382.037 | 0,62% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81.331.791 | 365.569 | 0,60% | Azioni |
| NORGES BANK | $76.627.007 | 344.422 | 0,56% | Azioni |
| UBS Group AG | $67.900.673 | 305.199 | 0,50% | Azioni |
| JANE STREET GROUP, LLC | $62.548.028 | 281.140 | 0,46% | Azioni |
| JANE STREET GROUP, LLC | $53.573.184 | 240.800 | 0,39% | Opzione Call |
| Holocene Advisors, LP | $52.875.709 | 237.665 | 0,39% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.100.176 | 216.200 | 0,35% | Opzione Put |
| ROYAL BANK OF CANADA | $47.787.000 | 214.787 | 0,35% | Azioni |
| DEUTSCHE BANK AG\ | $46.356.378 | 208.362 | 0,34% | Azioni |
| Quantinno Capital Management LP | $45.366.106 | 203.910 | 0,33% | Azioni |
| JPMORGAN CHASE & CO | $44.467.785 | 200.781 | 0,33% | Azioni |
| CITADEL ADVISORS LLC | $44.465.298 | 199.862 | 0,33% | Azioni |
| CITADEL ADVISORS LLC | $44.184.528 | 198.600 | 0,32% | Opzione Call |
| BARCLAYS PLC | $43.410.740 | 195.122 | 0,32% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $40.134.502 | 180.396 | 0,30% | Azioni |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37.089.700 | 241.328 | 0,27% | Azioni |
| Gotham Asset Management, LLC | $36.393.278 | 163.580 | 0,27% | Azioni |
| JANE STREET GROUP, LLC | $35.774.784 | 160.800 | 0,26% | Opzione Put |
| Doma Perpetual Capital Management LLC | $35.522.937 | 159.668 | 0,26% | Azioni |
| FIRST TRUST ADVISORS LP | $34.161.205 | 153.548 | 0,25% | Azioni |
| TODD ASSET MANAGEMENT LLC | $32.697.663 | 146.969 | 0,24% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32.011.312 | 143.884 | 0,24% | Azioni |
| Allianz Asset Management GmbH | $30.236.367 | 135.906 | 0,22% | Azioni |
| Toroso Investments, LLC | $29.297.520 | 257.878 | 0,22% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.480.460 | 119.024 | 0,19% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $26.377.896 | 118.563 | 0,19% | Azioni |
| Amundi | $25.967.198 | 116.717 | 0,19% | Azioni |
| FMR LLC | $25.475.535 | 114.507 | 0,19% | Azioni |
| Davidson Kempner Capital Management LP | $25.162.043 | 113.098 | 0,18% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 depositi | 13 Febbraio 2025 | 45,00% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 59 insider · 31 dirigenti · 25 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 Giugno 2026 S | 840.408 | 0 | 2 | $-14.532.097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 Maggio 2016 S | 18.766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 07 Maggio 2026 S | 132.434 | 0 | 1 | $-9.887.579 |
| Luis Borgen | Chief Financial Officer | 22 Marzo 2012 M | 18.517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 Marzo 2010 A | 33.604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 Marzo 2007 A | 31.250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 01 Luglio 2006 A | 10.000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 22 Settembre 2026 F | 86.604 | 0 | 2 | $-4.089.696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 Agosto 2024 S | 209.365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 Dicembre 2016 A | 4.688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 Giugno 2026 S | 109.194 | 0 | 2 | $-3.210.360 |
| James O Hearty | Chief Compliance Officer | 14 Maggio 2026 M | 22.389 | 0 | 2 | $-3.291.616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 Marzo 2026 A | 19.640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 Marzo 2023 F | 15.676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 Settembre 2020 M | 24.590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 01 Giugno 2020 F | 110.462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 02 Giugno 2019 F | 33.125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 Giugno 2017 M | 3.514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 Settembre 2015 M | 7.438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 04 Giugno 2015 S | 2.322.928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 Febbraio 2014 M | 8.990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 09 Settembre 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 02 Agosto 2013 G | 2.315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 Febbraio 2012 M | 17.491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 Giugno 2009 M | 5.547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 Febbraio 2009 M | 2.084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 Agosto 2008 M | 2.500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 05 Marzo 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 Luglio 2007 A | 6.250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 08 Maggio 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 04 Novembre 2005 M | 42.000 | 0 | 0 | $0 |
| Dennis W Pullin | Direttore | 15 Agosto 2026 A | 2.949 | 0 | 0 | $0 |
| Gregory J. Moore | Direttore | 15 Agosto 2026 A | 8.091 | 0 | 0 | $0 |
| Jason M. Hollar | Direttore | 15 Agosto 2026 A | 6.883 | 0 | 0 | $0 |
| Patricia M Arway | Direttore | 15 Agosto 2026 A | 27.223 | 0 | 0 | $0 |
| Adam H Schechter | Direttore | 15 Agosto 2026 A | 5.970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Direttore | 15 Agosto 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Direttore | 15 Agosto 2026 A | 9.803 | 0 | 0 | $0 |
| Barbara J Desoer | Direttore | 15 Agosto 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Direttore | 15 Maggio 2025 A | 19.982 | 0 | 0 | $0 |
| John M Nehra | Direttore | 15 Maggio 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Direttore | 15 Maggio 2023 A | 16.069 | 0 | 0 | $0 |
| Paula A Price | Direttore | 15 Maggio 2022 A | 1.395 | 0 | 0 | $0 |
| Shawn M Guertin | Direttore | 15 Maggio 2021 A | 1.105 | 0 | 0 | $0 |
| Pascal Desroches | Direttore | 15 Novembre 2020 A | 8.030 | 0 | 0 | $0 |
| William L Roper | Direttore | 11 Giugno 2020 A | 16.234 | 0 | 0 | $0 |
| Peter T Grauer | Direttore | 11 Giugno 2020 A | 76.204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Direttore | 31 Dicembre 2017 A | 10.764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Direttore | 11 Giugno 2012 A | 7.195 | 0 | 0 | $0 |
| Richard C Vaughan | Direttore | 13 Maggio 2010 A | 6.092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Direttore | 30 Giugno 2008 A | 3.256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Direttore | 31 Marzo 2007 A | 8.684 | 0 | 0 | $0 |
| Michele J Hooper | Direttore | 13 Maggio 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 17 Settembre 2020 S | 1.991.806 | 0 | 0 | $0 |
| Roger Valine | · | 30 Giugno 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 17 Dicembre 2015 M | 8.447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 16 Maggio 2007 G | 10.000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 25 Febbraio 2005 M | 3.000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 05 Maggio 2004 M | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 97 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5,19% | 213.947 NS | 31 Luglio 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3,36% | 13.006 NS | 31 Luglio 2026 | N-PORT |
| AZTD · Tidal Trust I | 3,06% | 4.824 NS | 31 Luglio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,44% | 106.663 NS | 31 Luglio 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,56% | 77.933 SH | 01 Ottobre 2026 | Giornaliero |
| AMOM · Exchange Listed Funds Trust | 1,41% | 1.399 NS | 31 Luglio 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,19% | 760 NS | 31 Luglio 2026 | N-PORT |
| IHF · iShares Trust | 0,85% | 61.700 SH | 11 Settembre 2026 | Giornaliero |
| JMID · Janus Detroit Street Trust | 0,46% | 456 NS | 31 Luglio 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 8.917 NS | 31 Luglio 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,34% | 4.688 NS | 31 Luglio 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 6.488 NS | 31 Luglio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9.914 SH | 19 Agosto 2026 | Giornaliero |
| ROSC · Lattice Strategies Trust | 0,27% | 691 NS | 31 Luglio 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22.551 SH | 01 Ottobre 2026 | Giornaliero |
| BKMC · BNY Mellon ETF Trust | 0,22% | 5.948 NS | 31 Luglio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,20% | 126.925 NS | 31 Luglio 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1.068.917 SH | 01 Ottobre 2026 | Giornaliero |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 15.260 NS | 31 Luglio 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 1.456 NS | 31 Luglio 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467.367 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 15.871 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 6.102 SH | 11 Settembre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,11% | 100.394 SH | 19 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,10% | 16.178 SH | 11 Settembre 2026 | Giornaliero |
| IYH · iShares Trust | 0,09% | 18.805 SH | 11 Settembre 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 4.161 SH | 01 Ottobre 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736.199 SH | 19 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,09% | 632 NS | 31 Luglio 2026 | N-PORT |
| SMMD · iShares Trust | 0,08% | 17.274 SH | 11 Settembre 2026 | Giornaliero |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 4.629 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 7.288 NS | 31 Luglio 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16.934 SH | 11 Settembre 2026 | Giornaliero |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 38.169 SH | 01 Ottobre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,06% | 121.442 NS | 31 Luglio 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3.244 SH | 01 Ottobre 2026 | Giornaliero |
| DUHP · Dimensional ETF Trust | 0,06% | 29.605 NS | 31 Luglio 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2.005 SH | 10 Settembre 2026 | Giornaliero |
| IWS · iShares Trust | 0,05% | 45.297 SH | 11 Settembre 2026 | Giornaliero |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,05% | 322 NS | 31 Luglio 2026 | N-PORT |
| IWR · iShares Trust | 0,04% | 131.978 SH | 11 Settembre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,04% | 5.974 NS | 31 Luglio 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 1.967 NS | 31 Luglio 2026 | N-PORT |
| XOEF · iShares Trust | 0,04% | 43 SH | 10 Settembre 2026 | Giornaliero |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15.586 SH | 01 Ottobre 2026 | Giornaliero |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,03% | 34.392 SH | 01 Ottobre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,03% | 13.203 NS | 31 Luglio 2026 | N-PORT |
| CHRI · Global X Funds | 0,02% | 8 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2.124 NS | 31 Luglio 2026 | N-PORT |
| EGLE · Global X Funds | 0,02% | 2 NS | 31 Luglio 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,02% | 7.420 SH | 19 Agosto 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18.428 SH | 19 Agosto 2026 | Giornaliero |
| IVE · iShares Trust | 0,02% | 53.283 SH | 11 Settembre 2026 | Giornaliero |
| IUSV · iShares Trust | 0,02% | 27.948 SH | 11 Settembre 2026 | Giornaliero |
| NEAR · iShares U.S. ETF Trust | 0,02% | 949.000 SH | 09 Settembre 2026 | Giornaliero |
| DSI · iShares Trust | 0,02% | 4.810 SH | 11 Settembre 2026 | Giornaliero |
| IWD · iShares Trust | 0,01% | 67.699 SH | 11 Settembre 2026 | Giornaliero |
| XRMI · Global X Funds | 0,01% | 30 NS | 31 Luglio 2026 | N-PORT |
| XYLD · Global X Funds | 0,01% | 1.746 NS | 31 Luglio 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 1.706 NS | 31 Luglio 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 27.844 SH | 11 Settembre 2026 | Giornaliero |
| XYLG · Global X Funds | 0,01% | 32 NS | 31 Luglio 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 121 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 9.492 NS | 31 Luglio 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,01% | 766 NS | 31 Luglio 2026 | N-PORT |
| TOPC · iShares Trust | 0,01% | 19 SH | 10 Settembre 2026 | Giornaliero |
| XVV · iShares Trust | 0,01% | 377 SH | 10 Settembre 2026 | Giornaliero |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 832.243 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.019.458 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 28.136 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.315 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2.714 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7.283 SH | 19 Agosto 2026 | Giornaliero |
| XTR · Global X Funds | 0,01% | 2 NS | 31 Luglio 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 225 NS | 31 Luglio 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 9.703 SH | 11 Settembre 2026 | Giornaliero |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 203 SH | 30 Settembre 2026 | Giornaliero |
| SPXL · Direxion Shares ETF Trust | 0,01% | 2.512 NS | 31 Luglio 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 404.382 SH | 11 Settembre 2026 | Giornaliero |
| IWB · iShares Trust | 0,01% | 22.249 SH | 11 Settembre 2026 | Giornaliero |
| IYY · iShares Trust | 0,01% | 1.374 SH | 10 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,01% | 8.841 SH | 10 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,01% | 41.624 SH | 11 Settembre 2026 | Giornaliero |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 24 SH | 30 Settembre 2026 | Giornaliero |
| XCLR · Global X Funds | 0,01% | 1 NS | 31 Luglio 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.542 SH | 01 Ottobre 2026 | Giornaliero |
| IWF · iShares Trust | 0,00% | 6.443 SH | 02 Settembre 2026 | Giornaliero |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7.000 | 30 Settembre 2026 | Giornaliero |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.838 SH | 19 Agosto 2026 | Giornaliero |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 Luglio 2026 | Giornaliero |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| ISCB · iShares Trust | · | 1.571 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 3.661 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 5.973 SH | 11 Settembre 2026 | Giornaliero |
| SMMV · iShares Trust | · | 1.837 SH | 01 Settembre 2026 | Giornaliero |
DVA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 13 analisti
COMPRA
Target mediano
$220.00
+23,1%
1 7,7%
Acquisto forte
6 46,2%
Compra
5 38,5%
Mantieni
1 7,7%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
7 analisti · 2026-09-27Target medio $219.86 +23,0%
Ora
Prezzo attuale $178.69
Basso$165.00
Media$219.86
Alto$270.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
BLUECHIP_DIP
Stop out
rischio 1
premio 2,08
ingresso
$179.50
R:R 2,08
BLUECHIP_DIP
Scaduto
rischio 1
premio 2,08
ingresso
$176.69
R:R 2,08
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 4, 2026